Filing Details
- Accession Number:
- 0000049071-21-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 21:07:31
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 21:07:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
49071 | Humana Inc | HUM | Hospital & Medical Service Plans (6324) | 610647538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782445 | M Susan Diamond | Humana Inc. 500 West Main Street Louisville KY 40202 | Segment President, Home Bus. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Humana Common | Acquisiton | 2021-02-19 | 1,862 | $0.00 | 3,774 | No | 4 | M | Direct | |
Humana Common | Disposition | 2021-02-19 | 637 | $377.42 | 3,137 | No | 4 | F | Direct | |
Humana Common | Acquisiton | 2021-02-19 | 931 | $0.00 | 4,068 | No | 4 | M | Direct | |
Humana Common | Disposition | 2021-02-19 | 302 | $377.42 | 3,766 | No | 4 | F | Direct | |
Humana Common | Disposition | 2021-02-23 | 1,580 | $376.02 | 2,186 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Humana Common | Options | Acquisiton | 2021-02-22 | 4,524 | $0.00 | 4,524 | $376.61 |
Humana Common | Restricted Stock Units | Disposition | 2021-02-19 | 931 | $0.00 | 931 | $0.00 |
Humana Common | Restricted Stock Units | Acquisiton | 2021-02-22 | 1,099 | $0.00 | 1,099 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,524 | 2028-02-22 | No | 4 | A | Direct | |
0 | No | 4 | M | Direct | ||
1,099 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Humana Common | 2,109 | Indirect | See Footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Humana Common | Options | $350.79 | 2027-02-24 | 4,298 | 4,298 | Direct | |
Humana Common | Restricted Stock Units | $0.00 | 282 | 282 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 1,023 | 1,023 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 582 | 582 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 570 | 570 | Direct | ||
Humana Common | Phantom Stock Units | $0.00 | 318 | 318 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-24 | 4,298 | 4,298 | Direct |
282 | 282 | Direct | |
1,023 | 1,023 | Direct | |
582 | 582 | Direct | |
570 | 570 | Direct | |
318 | 318 | Indirect |
Footnotes
- Shares held for the benefit of the reporting person as of January 31, 2021 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
- Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
- Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
- Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
- Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
- Restricted stock units granted to reporting person on 02/19/18, 931 shares vesting in three annual increments on 12/15/18, 12/15/19 and 12/15/20. and 931 shares vest fully three years from the date of grant. Shares reported are what remain unvested.
- Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.
- Restricted stock units granted to reporting person on 06/01/19, 100% of the award is vesting on 6/1/22.
- Restricted stock units granted to reporting person on 07/01/19, 33% of the award is vesting on 07/01/20, 07/01/21, and 07/01/22.
- Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
- Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
- Phantom Stock Units held for the benefit of reporting person as of January 31, 2021 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
- Includes Performance Stock Units that vested on 2/19/21.
- Reporting person transferred a total of 464 shares of direct ownership on December 18, 2021 pursuant to a Domestic Relations Order. Reporting person was afforded a filing exemption under Rule 16a-12, which extends to securities transferred to a DRO.
- Price reported is weighted avg sales price.